Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 4
2014 7
2015 20
2016 16
2017 32
2018 18
2019 5
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 29382782

94 results
Results by year
Filters applied: . Clear all
Page 1
Approval of Ogivri.
Rathore AS. Rathore AS. PDA J Pharm Sci Technol. 2018 Jan-Feb;72(1):1. doi: 10.5731/pdajpst.2018.001105. PDA J Pharm Sci Technol. 2018. PMID: 29382782 No abstract available.
ABP 980: A Trastuzumab Biosimilar.
Dhillon S. Dhillon S. BioDrugs. 2018 Oct;32(5):511-514. doi: 10.1007/s40259-018-0305-2. BioDrugs. 2018. PMID: 30264234 Review.
PF-05280014: A Trastuzumab Biosimilar.
Paik J. Paik J. BioDrugs. 2018 Oct;32(5):515-518. doi: 10.1007/s40259-018-0308-z. BioDrugs. 2018. PMID: 30280367 Review.
[Trastuzumab and its biosimilars].
Sarosiek T, Morawski P. Sarosiek T, et al. Pol Merkur Lekarski. 2018 May 25;44(263):253-257. Pol Merkur Lekarski. 2018. PMID: 29813044 Review. Polish.
Trial Validates Biosimilar for Trastuzumab.
[No authors listed] [No authors listed] Cancer Discov. 2016 Jul;6(7):686-7. doi: 10.1158/2159-8290.CD-NB2016-068. Epub 2016 Jun 8. Cancer Discov. 2016. PMID: 27277256
94 results